Preclinical and clinical evidence for IL-6 and CCL2 as potential mediators in the pathophysiology of psychosis

被引：0
|
作者：
Trippaers, C. [1 ,2 ]
Lee, B. J. [1 ]
Hayes, L. [1 ]
Fukudome, D. [1 ]
Namkung, H. [1 ]
Srivastava, R. [1 ]
Kung, J. [1 ]
Morimura, K. [1 ]
Kato, M. [1 ]
Jaaro-Peled, H. [1 ]
Kano, S. [1 ]
Kirkwood, A. [1 ]
Yang, K. [1 ]
Ishizuka, K. [1 ]
Brone, B. [2 ]
Saito, A. [1 ]
Sawa, A. [1 ]
机构：
[1] Johns Hopkins Univ Sch Med, Psychiat, Baltimore, MD USA
[2] Hasselt Univ, Neurosci, Hasselt, Belgium
来源：
GLIA | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T19-018B
引用
收藏
页码：E1059 / E1059
页数：1
相关论文
共 50 条
  • [21] Pro-inflammatory cytokines IL-6 and CCL2 suppress expression of circadian gene Period2 in mammary epithelial cells
    Yu, Chan-Wei
    Cheng, Kuo-Chih
    Chen, Ling-Chih
    Lin, Meng-Xuan
    Chang, Yi-Cheng
    Hwang-Verslues, Wendy W.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2018, 1861 (11): : 1007 - 1017
  • [22] P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia
    Shieh, Chu-Hsin
    Heinrich, Annette
    Serchov, Tsvetan
    van Calker, Dietrich
    Biber, Knut
    GLIA, 2014, 62 (04) : 592 - 607
  • [23] PA28γ acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma
    Liu, Sai
    Liu, Dongjuan
    Zeng, Xin
    Wang, Jiongke
    Liu, Jiajia
    Cheng, Junxin
    Lei, Kexin
    Bai, Hetian
    Ji, Ning
    Zhou, Min
    Jiang, Lu
    Dan, Hongxia
    Li, Jing
    Chen, Qianming
    CANCER LETTERS, 2018, 428 : 192 - 200
  • [24] IL-6和趋化因子CCL2与前列腺癌的关系及其诊断价值
    李伟
    赵海军
    常钰玲
    农垦医学, 2023, 45 (04) : 299 - 303
  • [25] Levels of Selected Aqueous Humor Mediators (IL-10, IL-17, CCL2, VEGF, FasL) in Diabetic Cataract
    Mitrovic, Sanja
    Kelava, Tomislav
    Sucur, Alan
    Grcevic, Danka
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2016, 24 (02) : 159 - 166
  • [26] IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets
    Unver, Nese
    McAllister, Florencia
    CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 41 : 10 - 17
  • [27] Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression
    Chen, Li-Mei
    Liu, Po-Yen
    Chen, Yen-An
    Tseng, Hong-Yu
    Shen, Pei-Chun
    Hwang, Pai-An
    Hsu, Hsin-Ling
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression
    Li-Mei Chen
    Po-Yen Liu
    Yen-An Chen
    Hong-Yu Tseng
    Pei-Chun Shen
    Pai-An Hwang
    Hsin-Ling Hsu
    Scientific Reports, 7
  • [29] IL-6 Mediates Macrophage Infiltration after Irradiation via Up-regulation of CCL2/CCL5 in Non-small Cell Lung Cancer
    Wang, Xin
    Yang, Xiaodong
    Tsai, Ying
    Yang, Li
    Chuang, Kuang-Hsiang
    Keng, Peter C.
    Lee, Soo Ok
    Chen, Yuhchyau
    RADIATION RESEARCH, 2017, 187 (01) : 50 - 59
  • [30] Markers for systemic inflammation (CRP, ESR, IL-6, IL-10, IL-33, CCL2/MCP-1), and the disease severity in patients with chronic spontaneous urticaria
    Valerieva, A.
    Velikova, T.
    Petkova, E.
    Krasimirova, E.
    Nedeva, D.
    Krusheva, B.
    Lazarova, T.
    Dimitrov, V
    Staevska, M.
    ALLERGY, 2017, 72 : 153 - 154
12345